GSK plc (GLAXF)
OTCMKTS
· Delayed Price · Currency is USD
20.24
-0.27 (-1.29%)
Jun 6, 2025, 1:12 PM EDT
GSK plc Employees
GSK plc had 68,629 employees as of December 31, 2024. The number of employees decreased by 1,583 or -2.25% compared to the previous year.
Employees
68,629
Change (1Y)
-1,583
Growth (1Y)
-2.25%
Revenue / Employee
$593,563
Profits / Employee
$59,358
Market Cap
82.94B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 68,629 | -1,583 | -2.25% |
| Dec 31, 2023 | 70,212 | 812 | 1.17% |
| Dec 31, 2022 | 69,400 | -20,696 | -22.97% |
| Dec 31, 2021 | 90,096 | -3,970 | -4.22% |
| Dec 31, 2020 | 94,066 | -5,371 | -5.40% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 374 |
| CytoDyn | 9 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
GSK plc News
- 14 days ago - GSK shares break six-session winning streak - Seeking Alpha
- 15 days ago - GSK wins EU backing for multiple myeloma drug, Blenrep - Seeking Alpha
- 15 days ago - Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD) - Business Wire
- 15 days ago - GSK wins FDA label expansion for asthma therapy Nucala in COPD - Seeking Alpha
- 15 days ago - GSK's asthma drug Nucala wins FDA's approval to treat 'smoker's lung' - Reuters
- 17 days ago - Pharma stocks rally: Glaxo surges 7%, Torrent gains after Q4; Gland steady post mixed results - Business Upturn
- 19 days ago - GSK's Blood-Cancer Treatment Combinations Approved in Japan - WSJ
- 20 days ago - Notable healthcare headlines for the week: UnitedHealth, Novo Nordisk and GSK in focus - Seeking Alpha